Traditional molecular markers for the characterization of breast cancer are estrogen receptor (ER), progesterone hormone receptor (PR) and Her2/neu; the standard method for their global assessment remains immunohistochemistry 3. This evidence concerns the gene ESR1 and breast cancer.